Unique ID issued by UMIN | UMIN000043563 |
---|---|
Receipt number | R000049748 |
Scientific Title | Efficacy of isCGM on HbA1c improvement and behavior in Japanese type 2 diabetic patient - multicenter randomized prospective study - |
Date of disclosure of the study information | 2021/03/10 |
Last modified on | 2021/06/28 14:22:00 |
Efficacy of isCGM on HbA1c improvement and behavior in Japanese type 2 diabetic patient
HANABI STUDY
Efficacy of isCGM on HbA1c improvement and behavior in Japanese type 2 diabetic patient - multicenter randomized prospective study -
HANABI STUDY
Japan |
Type 2 Diabetes Mellitus
Endocrinology and Metabolism |
Others
NO
To assess the efficacy of isCGM on HbA1c improvement and behavior in Japanese type 2 diabetic patient
Efficacy
Group differences in HbA1c change after 6 months of study
1)TIR: time in range
2)TBR: time below range
3)TAR: time above range
4)HbA1c (except after 6 months), fasting blood glucose, C-peptide, body weight
5) Within-group changes in TIR goal achievement rates and between-group comparisons
6) HbA1c goal achievement rates and between-group comparisons
7) Within-group changes in the composite endpoint of 5) and 6) and between-group comparisons
8) Changes in psychological and behavioral indicators (DTSQ)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Placebo
2
Treatment
Device,equipment |
isCGM (Freestyle Libre)
6 months
20 | years-old | <= |
75 | years-old | > |
Male and Female
1)SMBG user of type 2 diabetic patients treated with self-injection therapy (over 6 months treatment)
2)Adaptation for type 2 diabates on the attached document of Freestyle Libre
3)Patients for whom written consent can be obtained (those with capacity to consent)
1)Contraindication of Freestyle Libre on the attachment document
2)Patients with an HbA1c level of less than 7.0% (20 to 65 years old) and patients with an HbA1c level of less than 7.5% (65 to 75 years old)
3)Mentally handicapped patient unsuitable for study evaluation
4)Pregnant women
5)Poor prognostic patient with malignancy
6)Patient with progressive diabetic retinopathy
7)Less than eGFR 30 ml/min/1.73m2
8)Hemoglobinopathy
9)Exercise restricted patient
10)Patient in treatment with drugs affect blood glucose levels including steroids, anti-cancer drugs, interferon et al
11)Dementia
12)Patients with therapeutic contraindications to the use of Freestyle Libre
13)Patients deemed unsuitable for this study by the researcher in this study
300
1st name | Hidenori |
Middle name | |
Last name | Katsuta |
Tokyo Teishin Hospital
Department of Internal Medicine, Division of Endocrinology and Metabolism
102-8798
2-14-23 Fujimi Chiyoda, Tokyo
03-5214-7111
hkatsuta@tth-japanpost.jp
1st name | Keishi |
Middle name | |
Last name | Mori |
Shido Inc.
Research Office
140-0001
1-9-7 Kitashinagawa Shinagawa-ku Tokyo
03-4500-5075
info@shido.co.jp
Tokyo Teishin Hospital
Diabetes and Lifestyle Study Society
Other
Tomonaga Clinic
Japan Community Health care Organization Tokyo Shinjuku Medical Center
Tokyo Yamate Medical Center
Tokyo Teishin hospital medical ethics committee
1-14-23 Fujimi Chiyoda-ku Tokyo
03-5214-7111
ykonno@tth-japanpost.jp
NO
東京逓信病院(東京)
ともながクリニック(東京)
JCHO東京新宿メディカルセンター(東京)
東京山手メディカルセンター(東京)
2021 | Year | 03 | Month | 10 | Day |
Unpublished
Preinitiation
2021 | Year | 03 | Month | 05 | Day |
2021 | Year | 03 | Month | 05 | Day |
2021 | Year | 03 | Month | 10 | Day |
2021 | Year | 12 | Month | 01 | Day |
2021 | Year | 03 | Month | 09 | Day |
2021 | Year | 06 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049748